Skip to main content

Table 4 Multivariate analysis of PFS

From: The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy

Prognostic factors

Progression-Free-Survival

Odds ratio

95% CI

p

NLR

0.575

0.449–0.737

0.000

PLR

0.677

0.531–0.863

0.002

TNM stage

1.427

1.102–1.849

0.007

Tumor length

0.924

0.715–1.194

0.544

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us